Shreerang A Bhide

Summary

Publications

  1. doi request reprint Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer
    Shreerang A Bhide
    Royal Marsden Hospital, Sutton, Surrey, UK
    Radiother Oncol 103:88-91. 2012
  2. ncbi request reprint Metastatic breast cancer response after Exemestane withdrawal: a case report
    S A Bhide
    Cancer Centre at the Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
    Breast 13:66-8. 2004
  3. ncbi request reprint Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site
    Shreerang Bhide
    Department of Oncology Head and Neck, Royal Marsden Hopsital, London, United Kingdom
    Med Dosim 32:188-95. 2007
  4. doi request reprint Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy
    Shreerang A Bhide
    Royal Marsden Hospital, London, UK
    Radiother Oncol 97:86-91. 2010
  5. doi request reprint Radiation-induced xerostomia: pathophysiology, prevention and treatment
    S A Bhide
    Head and Neck Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK
    Clin Oncol (R Coll Radiol) 21:737-44. 2009
  6. doi request reprint Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers
    Aisha B Miah
    Head and Neck Unit, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom
    Int J Radiat Oncol Biol Phys 82:539-47. 2012
  7. doi request reprint Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study
    Shreerang A Bhide
    Institute of Cancer Research, London, United Kingdom
    Int J Radiat Oncol Biol Phys 76:1360-8. 2010
  8. doi request reprint Dose-response analysis of parotid gland function: what is the best measure of xerostomia?
    Aisha B Miah
    Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
    Radiother Oncol 106:341-5. 2013
  9. doi request reprint Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer
    Shreerang A Bhide
    The Institute of Cancer Research, London, UK
    Radiother Oncol 93:539-44. 2009
  10. doi request reprint Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck
    Kevin J Harrington
    Institute of Cancer Research, 237 Fulham Road, London, United Kingdom
    Clin Cancer Res 16:4005-15. 2010

Collaborators

Detail Information

Publications23

  1. doi request reprint Dose-response analysis of acute oral mucositis and pharyngeal dysphagia in patients receiving induction chemotherapy followed by concomitant chemo-IMRT for head and neck cancer
    Shreerang A Bhide
    Royal Marsden Hospital, Sutton, Surrey, UK
    Radiother Oncol 103:88-91. 2012
    ..The dose-response model described in this study could be useful for comparing acute mucositis rates for different dose-fractionation schedules when using IMRT for head and neck cancer...
  2. ncbi request reprint Metastatic breast cancer response after Exemestane withdrawal: a case report
    S A Bhide
    Cancer Centre at the Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
    Breast 13:66-8. 2004
    ..Withdrawal response to Tamoxifen is well documented. To our knowledge a similar response after Exemestane withdrawal has not been reported in the literature...
  3. ncbi request reprint Intensity modulated radiotherapy improves target coverage and parotid gland sparing when delivering total mucosal irradiation in patients with squamous cell carcinoma of head and neck of unknown primary site
    Shreerang Bhide
    Department of Oncology Head and Neck, Royal Marsden Hopsital, London, United Kingdom
    Med Dosim 32:188-95. 2007
    ..5 +/- 5.8) (P < 0.0001). There was a significant difference in parotid dose between plans with and without the inclusion of the nasopharynx. IMRT offers improved dose homogeneity in PTV1 and PTV2 and allows for parotid sparing...
  4. doi request reprint Characteristics of response of oral and pharyngeal mucosa in patients receiving chemo-IMRT for head and neck cancer using hypofractionated accelerated radiotherapy
    Shreerang A Bhide
    Royal Marsden Hospital, London, UK
    Radiother Oncol 97:86-91. 2010
    ..This study describes the acute response of oral and pharyngeal mucosa to chemo-IMRT schedules using different doses per fraction...
  5. doi request reprint Radiation-induced xerostomia: pathophysiology, prevention and treatment
    S A Bhide
    Head and Neck Unit, Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK
    Clin Oncol (R Coll Radiol) 21:737-44. 2009
    ..We present a review of published studies describing and reporting xerostomia and discuss advances made in the prevention and treatment of this common toxicity...
  6. doi request reprint Dose-escalated intensity-modulated radiotherapy is feasible and may improve locoregional control and laryngeal preservation in laryngo-hypopharyngeal cancers
    Aisha B Miah
    Head and Neck Unit, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom
    Int J Radiat Oncol Biol Phys 82:539-47. 2012
    ....
  7. doi request reprint Weekly volume and dosimetric changes during chemoradiotherapy with intensity-modulated radiation therapy for head and neck cancer: a prospective observational study
    Shreerang A Bhide
    Institute of Cancer Research, London, United Kingdom
    Int J Radiat Oncol Biol Phys 76:1360-8. 2010
    ....
  8. doi request reprint Dose-response analysis of parotid gland function: what is the best measure of xerostomia?
    Aisha B Miah
    Head and Neck Unit, The Royal Marsden NHS Foundation Trust, London, UK
    Radiother Oncol 106:341-5. 2013
    ..To describe the dose-response relationships for the different measures of salivary gland recovery following radical radiotherapy for locally advanced head and neck squamous cell cancers (LA-HNSCC)...
  9. doi request reprint Correlation between dose to the pharyngeal constrictors and patient quality of life and late dysphagia following chemo-IMRT for head and neck cancer
    Shreerang A Bhide
    The Institute of Cancer Research, London, UK
    Radiother Oncol 93:539-44. 2009
    ..Aim of this study was to correlate dose to pharyngeal constrictors (PC) with subjective and observer-based assessments of swallowing in patients with head and neck cancer undergoing concomitant chemo-IMRT...
  10. doi request reprint Phase I/II study of oncolytic HSV GM-CSF in combination with radiotherapy and cisplatin in untreated stage III/IV squamous cell cancer of the head and neck
    Kevin J Harrington
    Institute of Cancer Research, 237 Fulham Road, London, United Kingdom
    Clin Cancer Res 16:4005-15. 2010
    ....
  11. doi request reprint The effect of concomitant chemotherapy on parotid gland function following head and neck IMRT
    Aisha B Miah
    Head and Neck Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Surrey, UK
    Radiother Oncol 106:346-51. 2013
    ..To determine whether concomitant chemotherapy increases the incidence of high grade xerostomia following parotid-sparing intensity-modulated radiotherapy (IMRT) in patients with locally advanced head and neck squamous cell cancer...
  12. pmc Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
    Christopher M Nutting
    Head and Neck Unit, Royal Marsden Hospitals NHS Foundation Trust, London, UK
    Lancet Oncol 12:127-36. 2011
    ..Compared with conventional radiotherapy, intensity-modulated radiotherapy (IMRT) can reduce irradiation of the parotid glands. We assessed the hypothesis that parotid-sparing IMRT reduces the incidence of severe xerostomia...
  13. doi request reprint Changes in functional imaging parameters following induction chemotherapy have important implications for individualised patient-based treatment regimens for advanced head and neck cancer
    Ceri Powell
    The Royal Marsden NHS Trust, Surrey, United Kingdom
    Radiother Oncol 106:112-7. 2013
    ..Understanding the impact of IC on FI parameters is, therefore, essential...
  14. pmc The HSP90 inhibitor NVP-AUY922 radiosensitizes by abrogation of homologous recombination resulting in mitotic entry with unresolved DNA damage
    Shane Zaidi
    Targeted Therapy Team, Institute of Cancer Research, Chester Beatty Laboratories, London, United Kingdom
    PLoS ONE 7:e35436. 2012
    ..We sought to evaluate NVP-AUY922, the most potent HSP90 inhibitor yet reported, in preclinical radiosensitization studies...
  15. pmc Therapeutic effect of sodium iodide symporter gene therapy combined with external beam radiotherapy and targeted drugs that inhibit DNA repair
    Mohan Hingorani
    Targeted Therapy Team, The Institute of Cancer Research, London, UK
    Mol Ther 18:1599-605. 2010
    ..Therefore, combining NIS gene therapy and EBRT represents an ideal strategy to exploit the therapeutic benefits of novel radiosensitizers...
  16. doi request reprint Anemia during sequential induction chemotherapy and chemoradiation for head and neck cancer: the impact of blood transfusion on treatment outcome
    Shreerang A Bhide
    The Institute of Cancer Research, The Royal Marsden National Health Service Foundation Trust Hospital, London, United Kingdom
    Int J Radiat Oncol Biol Phys 73:391-8. 2009
    ..In this study, we review the incidence of anemia and the effect of a policy of hemoglobin (Hb) maintenance by blood transfusion on disease outcomes in these patients...
  17. ncbi request reprint Otological toxicity after postoperative radiotherapy for parotid tumours
    S A Bhide
    Head and Neck Unit, Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London SW3 6JJ, UK
    Clin Oncol (R Coll Radiol) 19:77-82. 2007
    ..In particular, the close proximity of the auditory apparatus, which receives a significant radiation dose, results in significant toxicity in a proportion of patients. Here we review auditory toxicity after radiation to the parotid bed...
  18. doi request reprint Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma
    C M Nutting
    Head and Neck Unit, Royal Marsden Hospital and Institute of Cancer Research, London, UK
    Ann Oncol 20:1275-9. 2009
    ..Treatment options for recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) are limited with response rates to cytotoxic chemotherapy of approximately 30% and median survival of 6 months...
  19. pmc Recent advances in radiotherapy
    S A Bhide
    Institute of Cancer Research and Royal Marsden Hospital, Fulham Road, London, UK
    BMC Med 8:25. 2010
    ..Various hardware and software tools are under investigation for optimal IGRT...
  20. doi request reprint The role of intensity-modulated radiotherapy in head and neck cancer
    S A Bhide
    Head and Neck Unit, The Institute of Cancer Research and The Royal Marsden Hospital, London and Surrey, United Kingdom
    Indian J Cancer 47:267-73. 2010
    ..The future of IMRT in head and neck cancers lies in exploring the use of biological imaging for dose-escalation using targeted dose painting...
  21. doi request reprint Radical radiotherapy for treatment of malignant parotid tumours: a single centre experience 1995-2005
    S A Bhide
    Head and Neck Oncology, Royal Marsden Hospital, London, United Kingdom
    Br J Oral Maxillofac Surg 47:284-9. 2009
    ....
  22. ncbi request reprint Reduce in variation and improve efficiency of target volume delineation by a computer-assisted system using a deformable image registration approach
    K S Clifford Chao
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, TX 7030, USA
    Int J Radiat Oncol Biol Phys 68:1512-21. 2007
    ....
  23. doi request reprint Enhanced in vitro and in vivo cytotoxicity of combined reovirus and radiotherapy
    Katie Twigger
    The Institute of Cancer Research, Targeted Therapy Laboratory, Cancer Research UK Centre for Cell and Molecular Biology, Chester Beatty Laboratories, London, United Kingdom
    Clin Cancer Res 14:912-23. 2008
    ..To test combination treatment schedules of reovirus and radiation in human and murine tumor cells in vitro and in vivo...